InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Friday, 12/20/2019 11:15:28 AM

Friday, December 20, 2019 11:15:28 AM

Post# of 639
News: $NLNK NewLink Genetics Announces FDA Approval of Ebola Vaccine V920 (ERVEBO®)

AMES, Iowa, Dec. 20, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) announced today that, after priority review, the FDA has granted approval of ERVEBO® , or Zaire Ebola virus vaccine V920 (rVSV∆G-ZEBOV-GP), as confirmed by our partner, Merck (NYS...

Read the whole news NLNK - NewLink Genetics Announces FDA Approval of Ebola Vaccine V920 (ERVEBO®)